Atrial natriuretic peptide (ANP) is a 28 amino-acid polypeptide secret
ed into the blood by atrial myocytes after atrial pressure and distens
ion. Although its role in humans is not clear, it can produce a variet
y of physiologic effects including vasodilatation, natriuresis, and su
ppression of the renin-angiotensin-aldosterone axis. These actions are
potentially useful in a variety of pathologic states such as hyperten
sion and congestive heart failure, and diverse methods to augment the
effects of ANP in these states have been devised. The results are exci
ting and, despite some problems, may lead to the pharmacologic use of
enhancement of ANP actions in several clinical disorders.